A carregar...
Next Generation Therapeutics for the Treatment of Myelofibrosis
Myelofibrosis is a myeloproliferative neoplasm characterized by splenomegaly, constitutional symptoms, bone marrow fibrosis, and a propensity towards transformation to acute leukemia. JAK inhibitors are the only approved therapy for myelofibrosis and have been successful in reducing spleen and sympt...
Na minha lista:
| Publicado no: | Cells |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8146033/ https://ncbi.nlm.nih.gov/pubmed/33925695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells10051034 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|